156 related articles for article (PubMed ID: 35276437)
61. Intracrine steroid production and mammalian target of rapamycin pathways in pulmonary lymphangioleiomyomatosis.
Adachi K; Miki Y; Saito R; Hata S; Yamauchi M; Mikami Y; Okada Y; Seyama K; Kondo T; Sasano H
Hum Pathol; 2015 Nov; 46(11):1685-93. PubMed ID: 26298231
[TBL] [Abstract][Full Text] [Related]
62. Stepwise Incremental Dose Schedule of Sirolimus Is Successfully Tolerated by a Patient With Lymphangioleiomyomatosis Who Was Initially Allergic to mTOR Inhibitors.
Seyama K; Komiyama E; Tsuchihashi H; Okura MK; Sekimoto Y; Mitsuishi Y
Cureus; 2024 Apr; 16(4):e58805. PubMed ID: 38784348
[TBL] [Abstract][Full Text] [Related]
63. Everolimus treatment of abdominal lymphangioleiomyoma in five women with sporadic lymphangioleiomyomatosis.
Mohammadieh AM; Bowler SD; Silverstone EJ; Glanville AR; Yates DH
Med J Aust; 2013 Jul; 199(2):121-3. PubMed ID: 23879512
[TBL] [Abstract][Full Text] [Related]
64. Chylothoraces after lung transplantation for lymphangioleiomyomatosis: review of the literature and utilization of a pleurovenous shunt.
Fremont RD; Milstone AP; Light RW; Ninan M
J Heart Lung Transplant; 2007 Sep; 26(9):953-5. PubMed ID: 17845935
[TBL] [Abstract][Full Text] [Related]
65. Lung transplantation for lymphangioleiomyomatosis: role of imaging in the assessment of complications related to the underlying disease.
Collins J; Müller NL; Kazerooni EA; McAdams HP; Leung AN; Love RB
Radiology; 1999 Feb; 210(2):325-32. PubMed ID: 10207410
[TBL] [Abstract][Full Text] [Related]
66. Lung transplantation for lymphangioleiomyomatosis: the French experience.
Reynaud-Gaubert M; Mornex JF; Mal H; Treilhaud M; Dromer C; Quétant S; Leroy-Ladurie F; Guillemain R; Philit F; Dauriat G; Grenet D; Stern M
Transplantation; 2008 Aug; 86(4):515-20. PubMed ID: 18724219
[TBL] [Abstract][Full Text] [Related]
67. Effects of sirolimus in lymphangioleiomyomatosis patients on lung cysts and pulmonary function: long-term follow-up observational study.
Kim C; Do KH; Cha J; Song JW; Lee SM; Lee KY
Eur Radiol; 2020 Feb; 30(2):735-743. PubMed ID: 31471750
[TBL] [Abstract][Full Text] [Related]
68. Protein expression of urotensin II, urotensin-related peptide and their receptor in the lungs of patients with lymphangioleiomyomatosis.
Kristof AS; You Z; Han YS; Giaid A
Peptides; 2010 Aug; 31(8):1511-6. PubMed ID: 20433884
[TBL] [Abstract][Full Text] [Related]
69. Is sirolimus a therapeutic option for patients with progressive pulmonary lymphangioleiomyomatosis?
Neurohr C; Hoffmann AL; Huppmann P; Herrera VA; Ihle F; Leuschner S; von Wulffen W; Meis T; Baezner C; Leuchte H; Baumgartner R; Zimmermann G; Behr J
Respir Res; 2011 May; 12(1):66. PubMed ID: 21600034
[TBL] [Abstract][Full Text] [Related]
70. MicroRNA-21 is induced by rapamycin in a model of tuberous sclerosis (TSC) and lymphangioleiomyomatosis (LAM).
Trindade AJ; Medvetz DA; Neuman NA; Myachina F; Yu J; Priolo C; Henske EP
PLoS One; 2013; 8(3):e60014. PubMed ID: 23555865
[TBL] [Abstract][Full Text] [Related]
71. Reduced risk of recurrent pneumothorax for sirolimus therapy after surgical pleural covering of entire lung in lymphangioleiomyomatosis.
Sakurai T; Arai T; Hirose M; Kojima K; Sakamoto T; Matsuda Y; Sugimoto C; Yoon HE; Inoue Y
Orphanet J Rare Dis; 2021 Nov; 16(1):466. PubMed ID: 34732225
[TBL] [Abstract][Full Text] [Related]
72. Recurrent lymphangioleiomyomatosis after living-donor lobar lung transplantation.
Chen F; Bando T; Fukuse T; Omasa M; Aoyama A; Hamakawa H; Fujinaga T; Shoji T; Sakai H; Hanaoka N; Wada H
Transplant Proc; 2006 Nov; 38(9):3151-3. PubMed ID: 17112924
[TBL] [Abstract][Full Text] [Related]
73. Prevention of alveolar destruction and airspace enlargement in a mouse model of pulmonary lymphangioleiomyomatosis (LAM).
Goncharova EA; Goncharov DA; Fehrenbach M; Khavin I; Ducka B; Hino O; Colby TV; Merrilees MJ; Haczku A; Albelda SM; Krymskaya VP
Sci Transl Med; 2012 Oct; 4(154):154ra134. PubMed ID: 23035046
[TBL] [Abstract][Full Text] [Related]
74. A Phase II Clinical Trial of an Aromatase Inhibitor for Postmenopausal Women with Lymphangioleiomyomatosis.
Lu C; Lee HS; Pappas GP; Dilling DF; Burger CD; Shifren A; Veeraraghavan S; Chapman JT; Parambil J; Ruoss SJ; Young LR; Hammes SR; Kopras EJ; Roads T; Krischer JP; McCormack FX;
Ann Am Thorac Soc; 2017 Jun; 14(6):919-928. PubMed ID: 28570161
[TBL] [Abstract][Full Text] [Related]
75. Interferon beta augments tuberous sclerosis complex 2 (TSC2)-dependent inhibition of TSC2-null ELT3 and human lymphangioleiomyomatosis-derived cell proliferation.
Goncharova EA; Goncharov DA; Chisolm A; Spaits MS; Lim PN; Cesarone G; Khavin I; Tliba O; Amrani Y; Panettieri RA; Krymskaya VP
Mol Pharmacol; 2008 Mar; 73(3):778-88. PubMed ID: 18094073
[TBL] [Abstract][Full Text] [Related]
76. Long-term stable lung function and second uncomplicated pregnancy on sirolimus in lymphangioleiomyomatosis (LAM).
Faehling M; Wienhausen-Wilke V; Fallscheer S; Trinajstic-Schulz B; Weber J; Leschke M
Sarcoidosis Vasc Diffuse Lung Dis; 2015 Sep; 32(3):259-64. PubMed ID: 26422572
[TBL] [Abstract][Full Text] [Related]
77. Clinical predictors of mortality and cause of death in lymphangioleiomyomatosis: a population-based registry.
Oprescu N; McCormack FX; Byrnes S; Kinder BW
Lung; 2013 Feb; 191(1):35-42. PubMed ID: 23007140
[TBL] [Abstract][Full Text] [Related]
78. [Lung transplantation in sporadic lymphangioleiomyomatosis: study of 7 cases].
Ansótegui Barrera E; Mancheño Franch N; Peñalver Cuesta JC; Vera-Sempere F; Padilla Alarcón J
Med Clin (Barc); 2013 Oct; 141(8):349-52. PubMed ID: 23937818
[TBL] [Abstract][Full Text] [Related]
79. Recent Advances in Mammalian Target of Rapamycin Inhibitor Use in Heart and Lung Transplantation.
Fine NM; Kushwaha SS
Transplantation; 2016 Dec; 100(12):2558-2568. PubMed ID: 27495747
[TBL] [Abstract][Full Text] [Related]
80. Sirolimus amelioration of clinical symptoms of recurrent lymphangioleiomyomatosis after living-donor lobar lung transplantation.
Sugimoto R; Nakao A; Yamane M; Toyooka S; Okazaki M; Aoe M; Seyama K; Date H; Oto T; Sano Y
J Heart Lung Transplant; 2008 Aug; 27(8):921-4. PubMed ID: 18656809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
